Previous Article | Next Article 
Journal of Virology, June 2000, p. 5655-5658, Vol. 74, No. 12
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Isolation and Characterization of a New Subtype of Borna
Disease Virus
Norbert
Nowotny,1,*
Jolanta
Kolodziejek,1
Christian O.
Jehle,2
Angelika
Suchy,3
Peter
Staeheli,2 and
Martin
Schwemmle2
Institute of Virology1
and Institute of Pathology and Forensic Veterinary
Medicine,3 University of Veterinary
Sciences, Vienna, A-1210 Vienna, Austria, and Department of
Virology, University of Freiburg, D-79008 Freiburg,
Germany2
Received 13 December 1999/Accepted 18 March 2000
 |
ABSTRACT |
Borna disease virus (BDV), the causative agent of severe
meningoencephalitis in a wide variety of animal species, has been considered to be genetically invariable and to form a single type within the genus Bornavirus of the family
Bornaviridae. BDV infections are of particular interest,
because for the first time a virus infection appears to be linked to
human psychiatric disorders. We now describe a new subtype of BDV
isolated from a horse which was euthanatized due to severe, incurable
neurological disease. The nucleotide sequence of this new strain, named
No/98, differs from the reference strains by more than 15%, and the
subtype is difficult to detect by standard reverse transcriptase PCR
protocols. The nucleotide exchanges of the novel BDV isolate have
surprisingly little effect on the primary structures of most viral
proteins, with the notable exception of the X protein (p10), which is
only 81% identical to its counterpart in reference strains. Our data indicate that the genome of BDV is far more variable than previously assumed and that naturally occurring subtypes may escape detection by
currently used diagnostic assays.
 |
INTRODUCTION |
Borna disease virus (BDV) is the
causative agent of severe meningoencephalitis in horses, sheep, and
other animal species in central Europe (7, 13, 21, 22), and
it is suspected to contribute to human psychiatric disorders worldwide
(1, 2, 6, 8-12, 14, 15, 20). The pathogenesis of Borna disease is mediated by a T-cell-dependent immune mechanism. All natural
isolates of BDV that have been available to date, independent of
species (humans, horses, sheep, cats, dogs, etc.), area (Europe, the
United States, Japan), and year of isolation (1929 to 1998), show a
remarkably high sequence conservation of the 8.9-kb RNA genome (5,
11, 16, 17). Human BDV isolates are 95 to 100% identical to
animal-derived BDV at the nucleotide level and are 97 to 100%
identical at the amino acid level (5, 11, 16). BDV is
therefore considered a potential zoonotic agent. Because serum antibody
titers are frequently low in naturally infected individuals and BDV
serology has several other limitations, reverse transcriptase PCR
(RT-PCR) technology using primers that match sequences of the viral N
or P genes (1, 2, 5, 6, 8, 9, 12, 15, 16, 17, 19) is now
widely used for the diagnosis of BDV infection. In this report, we
describe a novel subtype of BDV which escapes detection by currently
used diagnostic RT-PCR protocols.
 |
MATERIALS AND METHODS |
Immunohistochemistry.
Paraffin-embedded brain sections were
stained with the monoclonal antibody BO18, directed against the N
protein, and a polyclonal mouse antiserum, directed against the X
protein of BDV (3), as described previously (21,
22). Staining of cultured cells grown on glass coverslips was
carried out according to standard procedures, by using polyclonal
antisera raised against purified recombinant X and P proteins of BDV
He/80.
Sample preparation and RNA extraction.
Samples from
hippocampus and rhinencephalon were homogenized by using liquid
nitrogen and were resuspended in diethyl pyrocarbonate-treated water.
Following low-speed centrifugation, 140 µl of supernatant was used
for RNA extraction, employing the QIAamp viral RNA kit (QIAGEN).
PCR assays.
In order to amplify overlapping genome fragments
of the causative BDV strain, named No/98, RT-PCR was performed with a
large number of different oligonucleotide primer pairs. cDNA synthesis and PCR were carried out in a single step by using the Titan One Tube
RT-PCR Kit (Boehringer Mannheim/Roche). A 5-µl volume of extract,
containing 50 pmol of RNA (approximately 0.2 µg of RNA), was used in
each RT-PCR. For the experiments shown below (see Fig. 4A and B), the
primer pairs described by Sorg and Metzler (19) were
employed, because PCR assays using these oligonucleotide primers proved
best for the detection of classical BDV in a recent multicenter study.
Nested PCR (see Fig. 4B) was carried out by using 3 µl of the RT-PCR
product, Taq polymerase from Promega, and a
MgCl2 concentration of 1.5 mM. For the RT-PCR experiment shown below (see Fig. 4C), the forward primer was
5'-CCTGGCATCCTGTGACTATT-3', and the reverse primer was
5'-ATCTGCTCTTGGCTGTGTCT-3' (nucleotide positions 3863 to
3882 and 4254 to 4235 of strain V, respectively).
Sequence analysis.
PCR products were usually sequenced
directly (in both directions) without subcloning into plasmid vectors,
by using an automated DNA sequencer (ABI PRISM 310 Genetic Analyzer;
Perkin-Elmer); only a 0.65-kb fragment of the BDV isolate No/98 was
cloned into pCR2.1 by using the TA-ligation procedure as described by
the manufacturer (Invitrogen). The software package DNAStar 3 was used
for sequence alignment and for construction of the phylogenetic trees.
Isolation of BDV No/98 from frozen brain material.
Specimens
from hippocampus and rhinencephalon were homogenized and added to
early-passage cultures of young rabbit brain cells. After foci of
infected cells were visualized by indirect immunofluorescence analysis,
uninfected monkey Vero cells were added. After six cell passages, most
rabbit cells were lost and the virus isolate had infected a high
percentage of the Vero cells.
Nucleotide sequence accession number.
The sequence of the
genome fragment of the new BDV strain described here was submitted to
GenBank under accession no. AF136236.
 |
RESULTS AND DISCUSSION |
The diseased animal was a 7-year-old pony stallion, originating
from the Austrian federal state of Styria, where no cases of Borna
disease had been previously recorded. Also, the animal had never been
in regions in which BDV is endemic. The animal's clinical and
histopathological picture matched that of classical Borna disease; this
preliminary diagnosis was confirmed by immunohistochemical detection of
BDV antigen in paraffin-embedded brain sections (Fig. 1). Unexpectedly, however, BDV RNA was
not detected in frozen brain material by RT-PCR with several primer
pairs that routinely give reliable results, indicating major sequence
differences from previously isolated BDV strains. To verify this, we
performed PCR on cDNA samples from the brain of this horse using a
large array of primer pairs, including standard primers for classical BDV as well as primers specifically designed for this novel BDV strain.
Using this PCR strategy, we generated overlapping fragments of the
viral genome that were sequenced directly. The compiled sequence data
yielded information on a large fragment of the genome of the new BDV
strain, designated No/98, that corresponds to nucleotide positions 25 to 4234 of reference strain V; this fragment represents almost half of
the entire BDV genome, including the complete open reading frames
(ORFs) of the viral N, X, P, M and G genes and a small part of the L
gene (Fig. 2A). The No/98 sequence was
strictly colinear with that of reference strain V, except for a
three-nucleotide deletion at positions 90 to 92 that deletes alanine 13 of the N protein, a single nucleotide deletion at position 1170, and a
three-nucleotide (GCA) insertion after nucleotide 1204, both located in
the first intergenic region between the N and X ORFs. The overall
sequence identities between No/98 and the two reference strains V and
He/80 were 84.2 and 84.0%, respectively (Fig. 2B). The nucleotide
exchanges were distributed fairly evenly over the entire region that we
have sequenced. Within the coding sequences of the N, P, M, G, and L
genes, most nucleotide exchanges were silent, because they frequently
affected the third positions of the codons. Consequently, the amino
acid sequences were more than 93% identical to their counterparts in
strains V and He/80. When conservative amino acid substitutions were
taken into account, similarities were more than 96% (Fig. 2B). A
different situation emerged for the X protein that is encoded by an ORF
which overlaps the P ORF. Here, most nucleotide exchanges were not
silent, and the X protein of No/98 exhibited only about 81% identity
to its counterparts in strains V and He/80 (Fig. 2B). More careful
inspection (Fig. 2C) demonstrated a highly biased distribution of
nucleotide exchanges which strongly favored conservation of the P ORF
over the X ORF, indicating that the latter protein can tolerate more variation. It is of interest to note, however, that the
N-terminal region of the X protein, which harbors a nuclear export
sequence (M. Salvatore, R. E. O'Neill, M. Schwemmle, P. Palese,
and W. I. Lipkin, Abstr. Bornavir. Meet. 1998, abstr. V3,
1998) and a domain that mediates interactions with the P protein
(Salvatore et al., Abstr. Bornavir. Meet. 1998), was completely
invariant. A more variable region within the second transcription unit
was also described in highly conserved BDV isolates (11,
17).

View larger version (71K):
[in this window]
[in a new window]
|
FIG. 1.
Immunohistochemical staining of
paraffin-embedded brain tissue by using the avidin-biotin complex
technique and the monoclonal antibody BO18. (A) Specifically labeled
neuron within the hippocampus region (magnification, ×335). (B)
Positive immunostaining of hippocampal neurons. Note the numerous
intranuclear Joest-Degen inclusion bodies (arrows), which are
considered to be characteristic of BDV infection (magnification,
×335).
|
|

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 2.
Comparison of nucleotide and amino acid
sequences of BDV No/98 and common laboratory strains. (A) Gene order
and coding strategy of BDV. Overlapping RT-PCR products of No/98
corresponding to nucleotide positions 25 to 4234 of reference strain V
(3) were sequenced. This fragment includes the complete
coding sequences for the viral proteins N, X, P, M, and G and part of
the L gene, as indicated. (B) Comparison of nucleotide (nt) and amino
acid (aa) sequences of No/98 and laboratory strains V (3)
and He/80 (4). Percentage of overall sequence identity (all)
or sequence identities of the particular gene products at nucleotide
and amino acid levels are indicated. Numbers in parentheses show
percentage of sequence similarity when conserved amino acid exchanges
are taken into account. Amino acid exchanges were rated conservative
when the affected residues had similar biochemical properties. Any
exchanges within the following groups of amino acids were considered
conservative (single letter code): AILVM, STC, FY, NQ, WF, DE, and KR.
Numbers boxed with gray highlight the striking dissimilarity of the X
gene product. (C) Strongly biased conservation of the P protein
sequence in the X-P gene overlap region. Positions of
nonconservative amino acid exchanges in the X (n = 14)
and P (n = 3) proteins are indicated by vertical
bars. The comparison of strains V and No/98 is shown.
|
|
To elucidate the relationship between No/98 and previously known BDV
strains, we constructed phylogenetic trees based on published nucleotide sequences of N and P gene fragments (Fig.
3). This comparison included the
prototype strains V (3), He/80 (4), WT-1
(17), and MDCK (9) and various BDV-derived
nucleotide sequences found in blood samples of humans from Germany
(1, 5) and Japan (9). As previously noted by
others (5, 11, 16, 17), all BDV strains that had been
previously recognized had shown highly similar nucleotide sequences. In
sharp contrast, No/98 occupies a unique position in both phylogenetic
trees, indicating that it may represent the first member of a novel BDV
subtype.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 3.
Phylogenetic trees of BDV strains. Nucleotide sequence
comparisons of fragments from the N gene coding region (corresponding
to nucleotides 262 to 829 of reference strain V) and from the P gene
coding region (corresponding to nucleotides 1482 to 1814 of reference
strain V) were performed. Distances between strains indicate percentage
of sequence divergence. Sequence information used to construct these
trees was taken from the following sources: No/98, this report and
GenBank no. AF136236; V, reference 3 and GenBank no.
U04608; He/80, reference 4 and GenBank no. L27077;
WT-1 N gene, reference 17 and GenBank no. S67502;
WT-1 P gene, reference 17 and GenBank no. S67507;
Hu1 N gene, reference 1 and GenBank no. U58594; Hu1
P gene, reference 5 and GenBank no. L76234; Hu3
N gene, reference 1 and GenBank no. U58596; Hu3 P
gene, reference 5 and GenBank no. L76236. Sequences
designated MDCK, D1-3, D2-1, and H2-1 were taken from the work of Iwata
et al. (9).
|
|
To study the biological properties of No/98, we isolated this virus
from frozen brain material by using cultures of primary young rabbit
brain cells. Viral replication was monitored by indirect immunofluorescence analysis. The newly isolated virus could be transmitted to cultures of Vero monkey cells, in which it spread quickly without inducing a cytopathic effect. Vero cells infected with No/98 showed strong nuclear staining with monospecific antiserum raised against either X or P of strain He/80. To verify that the Vero
cells were indeed infected with No/98, we performed RT-PCR on RNA from
the persistently infected Vero cell culture. The amplified 0.65-kb
fragment (corresponding to nucleotide positions 1202 to 1856) included
the complete X ORF and part of the intergenic region between the N and
X genes. Its sequence precisely matched the No/98 sequence previously
established by direct analysis of horse brain material. All nucleotide
exchanges and the three-base insertion after position 1204 were also
present in the virus isolate, indicating that the genome of No/98 did
not rapidly acquire major alterations during replication in Vero cells.
Sequence comparisons revealed that currently used diagnostic RT-PCR
assays employ primer pairs that only poorly match the No/98 sequence.
To test if they would still detect this virus subtype, we prepared
mixtures of 5 × 105 uninfected Vero cells and various
numbers of cells infected with either BDV strain He/80 or No/98,
extracted RNA from these cell mixtures, and used samples for reverse
transcription. Standard (nonnested) PCR for detection of transcripts
from the BDV N gene yielded the expected amplification products with
all cell mixtures containing between 5,000 and 5 He/80-infected cells
(Fig. 4A). By contrast, no amplification
products were observed with cell mixtures containing high or low
numbers of No/98-infected cells (Fig. 4A). Only when nested PCR was
performed (Fig. 4B) did the samples containing 5,000 and 500 No/98-infected cells become weakly positive. When other primer pairs
that better match both viral genomes were used, No/98- and
He/80-infected cells were detected at similar sensitivities (Fig. 4C).
The above experiment was repeated with other published RT-PCR protocols
and showed results very similar to those presented in Fig. 4A and B;
they either failed completely to amplify BDV No/98 sequences or
exhibited significantly lower sensitivities in detecting this novel BDV
subtype, even when altering the PCR conditions.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 4.
No/98 is poorly recognized by conventional diagnostic
RT-PCR assays. To examine at which sensitivity levels a published
RT-PCR assay is able to detect the novel BDV subtype compared to the
classical subtype, we prepared cell mixtures, each containing 5 × 105 uninfected Vero cells and the indicated numbers of Vero
cells infected with either BDV No/98 or He/80 and subjected them to PCR
analysis. (A) Conventional RT-PCR (19); (B) conventional
nested PCR (19); (C) modified RT-PCR using primer pairs
(described above) that amplify both No/98 and He/80 genomes.
|
|
The identification of a new BDV field isolate that escapes detection by
currently used diagnostic assays has far-reaching implications for
proper diagnosis of BDV in, for example, human neuropsychiatric
disorders. The new findings imply that previous studies, which relied
on RT-PCR technology, might have underestimated the true prevalence
rates of human BDV infections and might also have missed etiological
correlations between BDV infection and certain neuropsychiatric
disorders. The isolation of a BDV with a highly variant genome
disproves the general opinion of high sequence conservation of all BDV
genomes; the possibility that further, yet unidentified, BDV subtypes
do exist should be considered seriously.
 |
ACKNOWLEDGMENTS |
This work was supported by grants from the Austrian federal state
of Vorarlberg, the state of Baden-Württemberg, and the Deutsche Forschungsgemeinschaft.
We thank Otto Haller for critical reading of the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute of
Virology, University of Veterinary Sciences, Vienna,
Veterinärplatz 1, A-1210 Vienna, Austria. Phone: 43 1 25077-2304. Fax: 43 1 25077-2390. E-mail:
Norbert.Nowotny{at}vu-wien.ac.at.
 |
REFERENCES |
| 1.
|
Bode, L.,
R. Dürrwald,
F. A. Rantam,
R. Ferszt, and H. Ludwig.
1996.
First isolates of infectious human Borna disease virus from patients with mood disorders.
Mol. Psychiatry
1:200-212[Medline].
|
| 2.
|
Bode, L.,
W. Zimmermann,
R. Ferszt,
F. Steinbach, and H. Ludwig.
1995.
Borna disease virus genome transcribed and expressed in psychiatric patients.
Nat. Med.
1:232-236[CrossRef][Medline].
|
| 3.
|
Briese, T.,
A. Schneemann,
A. J. Lewis,
Y.-S. Park,
S. Kim,
H. Ludwig, and W. I. Lipkin.
1994.
Genomic organization of Borna disease virus.
Proc. Natl. Acad. Sci. USA
91:4362-4366[Abstract/Free Full Text].
|
| 4.
|
Cubitt, B.,
C. Oldstone, and J. C. de la Torre.
1994.
Sequence and genome organization of Borna disease virus.
J. Virol.
68:1382-1396[Abstract/Free Full Text].
|
| 5.
|
de la Torre, J. C.,
L. Bode,
R. Dürrwald,
B. Cubitt, and H. Ludwig.
1996.
Sequence characterization of human Borna disease virus.
Virus Res.
44:33-44[CrossRef][Medline].
|
| 6.
|
de la Torre, J. C.,
D. Gonzalez-Dunia,
B. Cubitt,
M. Mallory,
N. Mueller-Lantzsch,
F. A. Grässer,
L. A. Hansen, and E. Masliah.
1996.
Detection of Borna disease virus antigen and RNA in human autopsy brain samples from neuropsychiatric patients.
Virology
223:272-282[CrossRef][Medline].
|
| 7.
|
Dürrwald, R., and H. Ludwig.
1997.
Borna disease virus (BDV), a (zoonotic?) worldwide pathogen. A review of the history of the disease and the virus infection with comprehensive bibliography.
J. Vet. Med. Ser. B
44:147-184.
|
| 8.
|
Haga, S.,
Y. Motoi,
K. Ikeda, and the Japan Bornavirus Study Group.
1997.
Borna disease virus and neuropsychiatric disorders.
Lancet
350:592-593.
|
| 9.
|
Iwata, Y.,
K. Takahashi,
X. Peng,
K. Fukuda,
K. Ohno,
T. Ogawa,
K. Gonda,
N. Mori,
S. Niwa, and S. Shigeta.
1998.
Detection and sequence analysis of Borna disease virus p24 RNA from peripheral blood mononuclear cells of patients with mood disorders or schizophrenia and of blood donors.
J. Virol.
72:10044-10049[Abstract/Free Full Text].
|
| 10.
|
Nowotny, N., and J. Windhaber.
1997.
Borna disease virus and neuropsychiatric disorders.
Lancet
350:593[Medline].
|
| 11.
|
Planz, O.,
C. Rentzsch,
A. Batra,
A. Batra,
T. Winkler,
M. Büttner,
H.-J. Rziha, and L. Stitz.
1999.
Pathogenesis of Borna disease virus: granulocyte fractions of psychiatric patients harbor infectious virus in the absence of antiviral antibodies.
J. Virol.
73:6251-6256[Abstract/Free Full Text].
|
| 12.
|
Planz, O.,
C. Rentzsch,
A. Batra,
H.-J. Rziha, and L. Stitz.
1998.
Persistence of Borna disease virus-specific nucleic acid in blood of psychiatric patient.
Lancet
352:623[Medline].
|
| 13.
|
Richt, J. A.,
I. Pfeuffer,
M. Christ,
K. Frese,
K. Bechter, and S. Herzog.
1997.
Borna disease virus infection in animals and humans.
Emerg. Infect. Dis.
3:343-352[Medline].
|
| 14.
|
Rott, R.,
S. Herzog,
B. Fleischer,
A. Winokur,
J. Amsterdam,
W. Dyson, and H. Koprowski.
1985.
Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders.
Science
228:755-756[Abstract/Free Full Text].
|
| 15.
|
Salvatore, M.,
S. Morzunov,
M. Schwemmle,
W. I. Lipkin, and the Bornavirus Study Group.
1997.
Borna disease virus in brains of North American and European people with schizophrenia and bipolar disorder.
Lancet
349:1813-1814[CrossRef][Medline].
|
| 16.
|
Sauder, C.,
A. Müller,
B. Cubitt,
J. Mayer,
J. Steinmetz,
W. Trabert,
B. Ziegler,
K. Wanke,
N. Mueller-Lantzsch,
J. C. de la Torre, and F. A. Grässer.
1996.
Detection of Borna disease virus (BDV) antibodies and BDV RNA in psychiatric patients: evidence for high sequence conservation of human blood-derived BDV RNA.
J. Virol.
70:7713-7724[Abstract].
|
| 17.
|
Schneider, P. A.,
T. Briese,
W. Zimmermann,
H. Ludwig, and W. I. Lipkin.
1994.
Sequence conservation in field and experimental isolates of Borna disease virus.
J. Virol.
68:63-68[Abstract/Free Full Text].
|
| 18.
|
Schwemmle, M.,
M. Salvatore,
L. Shi,
J. Richt,
C. H. Lee, and W. I. Lipkin.
1998.
Interactions of the Borna disease virus P, N, and X proteins and their functional implications.
J. Biol. Chem.
273:9007-9012[Abstract/Free Full Text].
|
| 19.
|
Sorg, I., and A. Metzler.
1995.
Detection of Borna disease virus RNA in formalin-fixed, paraffin-embedded brain tissues by nested PCR.
J. Clin. Microbiol.
33:821-823[Abstract].
|
| 20.
|
VandeWoude, S.,
J. A. Richt,
M. C. Zink,
R. Rott,
O. Narayan, and J. E. Clements.
1990.
A Borna virus cDNA encoding a protein recognized by antibodies in humans with behavioral diseases.
Science
250:1278-1281[Abstract/Free Full Text].
|
| 21.
|
Weissenböck, H.,
N. Nowotny,
P. Caplazi,
J. Kolodziejek, and F. Ehrensperger.
1998.
Borna disease in a dog with lethal meningoencephalitis.
J. Clin. Microbiol.
36:2127-2130[Abstract/Free Full Text].
|
| 22.
|
Weissenböck, H.,
A. Suchy,
P. Caplazi,
S. Herzog, and N. Nowotny.
1998.
Borna disease in Austrian horses.
Vet. Rec.
143:21-22[Free Full Text].
|
Journal of Virology, June 2000, p. 5655-5658, Vol. 74, No. 12
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Poenisch, M., Wille, S., Staeheli, P., Schneider, U.
(2008). Polymerase Read-Through at the First Transcription Termination Site Contributes to Regulation of Borna Disease Virus Gene Expression. J. Virol.
82: 9537-9545
[Abstract]
[Full Text]
-
Bukovsky, C., Schmoll, F., Revilla-Fernandez, S., Weissenbock, H.
(2007). Studies on the aetiology of non-suppurative encephalitis in pigs. Vet Rec.
161: 552-558
[Abstract]
[Full Text]
-
Kolodziejek, J., Durrwald, R., Herzog, S., Ehrensperger, F., Lussy, H., Nowotny, N.
(2005). Genetic clustering of Borna disease virus natural animal isolates, laboratory and vaccine strains strongly reflects their regional geographical origin. J. Gen. Virol.
86: 385-398
[Abstract]
[Full Text]
-
Poenisch, M., Unterstab, G., Wolff, T., Staeheli, P., Schneider, U.
(2004). The X protein of Borna disease virus regulates viral polymerase activity through interaction with the P protein. J. Gen. Virol.
85: 1895-1898
[Abstract]
[Full Text]
-
Kobayashi, T., Zhang, G., Lee, B.-J., Baba, S., Yamashita, M., Kamitani, W., Yanai, H., Tomonaga, K., Ikuta, K.
(2003). Modulation of Borna Disease Virus Phosphoprotein Nuclear Localization by the Viral Protein X Encoded in the Overlapping Open Reading Frame. J. Virol.
77: 8099-8107
[Abstract]
[Full Text]
-
Geib, T., Sauder, C., Venturelli, S., Hassler, C., Staeheli, P., Schwemmle, M.
(2003). Selective Virus Resistance Conferred by Expression of Borna Disease Virus Nucleocapsid Components. J. Virol.
77: 4283-4290
[Abstract]
[Full Text]
-
Nishino, Y., Kobasa, D., Rubin, S. A., Pletnikov, M. V., Carbone, K. M.
(2002). Enhanced Neurovirulence of Borna Disease Virus Variants Associated with Nucleotide Changes in the Glycoprotein and L Polymerase Genes. J. Virol.
76: 8650-8658
[Abstract]
[Full Text]
-
Wolff, T., Unterstab, G., Heins, G., Richt, J. A., Kann, M.
(2002). Characterization of an Unusual Importin alpha Binding Motif in the Borna Disease Virus p10 Protein That Directs Nuclear Import. J. Biol. Chem.
277: 12151-12157
[Abstract]
[Full Text]
-
Kraus, I., Eickmann, M., Kiermayer, S., Scheffczik, H., Fluess, M., Richt, J. A., Garten, W.
(2001). Open Reading Frame III of Borna Disease Virus Encodes a Nonglycosylated Matrix Protein. J. Virol.
75: 12098-12104
[Abstract]
[Full Text]
-
Pleschka, S., Staeheli, P., Kolodziejek, J., Richt, J. A., Nowotny, N., Schwemmle, M.
(2001). Conservation of coding potential and terminal sequences in four different isolates of Borna disease virus. J. Gen. Virol.
82: 2681-2690
[Abstract]
[Full Text]
-
Carbone, K. M.
(2001). Borna Disease Virus and Human Disease. Clin. Microbiol. Rev.
14: 513-527
[Abstract]
[Full Text]
-
Fukuda, K., Takahashi, K., Iwata, Y., Mori, N., Gonda, K., Ogawa, T., Osonoe, K., Sato, M., Ogata, S.-i., Horimoto, T., Sawada, T., Tashiro, M., Yamaguchi, K., Niwa, S.-i., Shigeta, S.
(2001). Immunological and PCR Analyses for Borna Disease Virus in Psychiatric Patients and Blood Donors in Japan. J. Clin. Microbiol.
39: 419-429
[Abstract]
[Full Text]
-
Staeheli, P., Sauder, C., Hausmann, J., Ehrensperger, F., Schwemmle, M.
(2000). Epidemiology of Borna disease virus. J. Gen. Virol.
81: 2123-2135
[Full Text]
-
Formella, S., Jehle, C., Sauder, C., Staeheli, P., Schwemmle, M.
(2000). Sequence Variability of Borna Disease Virus: Resistance to Superinfection May Contribute to High Genome Stability in Persistently Infected Cells. J. Virol.
74: 7878-7883
[Abstract]
[Full Text]